CompletedNot Applicable

A Performance Study Comparing the EyeMirage (Test Device) to Standard of Care (Reference Device) in Patients 18 to 65 Years of Age Undergoing Standard Eye Examinations Such as Visual Acuity, Visual Field, Color Vision, and Self-Paced Saccade for Various Conditions

Canada160 participantsStarted 2025-06-13

Plain-language summary

This study will assess the effectiveness and accuracy of results of a new device for eye function testing. This will be done by comparing results of four eye tests that are done through the current standard used in eye clinics and that of this new device. Participants of this study will undergo the four eye tests using both the new device and the standard of care devices. The study will be done in one visit to the eye clinic. Thirty days after the eye tests were done, participants will be called by the clinic for a general follow-up and to discuss any problems, if needed.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Neurodegenerative diseases such as dementia-like Alzheimer's disease, posterior cortical atrophy
✕. Movement disorders such as Parkinson's disease and Parkinsonism tremors
✕. Multiple sclerosis, stroke or any other neurological or physical conditions with paresis or plegia (i.e. weakness or paralysis of the limbs)

What they're measuring

Accuracy and Reliability of EyeMirage Test Results from Four Elements of Visual Testing in Comparison to Current Standard of Care

Timeframe: From enrollment to the end of follow-up visit at Day 30 + 7 days

Trial details

NCT IDNCT06908967

SponsorNeuroptek Corporation Inc.

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-02-24

View on ClinicalTrials.gov More Visual Function trials